How has Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A performed historically?

The Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A is currently trading down -0.65% on an intraday basis in the past week the index rose 3.68%. The index has been up 29.62% in the past quarter and rose 33.97% in the past year. You can view this in the overview section.

What is Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A Annual Revenue?

Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A Annual Revenue rose 56.6%, in the last year to $423.24 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A Annual Net Profit?

Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A Annual Net Profit fell 406.68% in the last year to $43.19 M. Its sector's average net profit growth for the last fiscal year was -11.04%.

What is Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A Price to Earning Ratio?

Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A Price to Earning Ratio is -111.72, which is negative.

What is Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A Quarterly Revenue?

Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A Quarterly Revenue rose 72.54% YoY to $137.78 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A Quarterly Net profit?

Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A Quarterly Net profit rose 148.23% YoY to $8.54 M. Its sector's average net profit growth YoY for the quarter was -212.78%.

What is Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A Debt to Equity Ratio?

Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A Debt to Equity Ratio of 0.02 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A Return on Equity(ROE)?

Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A Return on Equity(ROE) for the last financial year was -9.85%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A Mutual Fund Holding?

Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A Mutual Fund Holding decreased by 0.26% in the last quarter to 26.44.

What is Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A Promoter Share Holding?

Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A Promoter Share Holding increased by 0.08% in the most recent quarter to 1.77%.

What is Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A Institutional Holding?

Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A Institutional Holding decreased by 2.61% in the last quarter to 50.63.

Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A XNAS: KNSA

Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Name: Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A
Rating: 1.626236125
Author: Trendlyne DVM scores

Momentum Trap

about

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical...

25.95 -0.17 (-0.65%)

49.31% Gain from 52W Low

368.7K XNAS Volume

XNAS 22 May, 2025 4:00 PM (EDT)

Low Financial Strength

27.8 / 100

Expensive Valuation

15.3 / 100

Technically Neutral

59.2 / 100

Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

1Yr Price target upside is 46%

6 analysts

Kiniksa Pharmaceuticals Lt... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical...

49.31% Gain from 52W Low

SWOT Analysis

Kiniksa Pharmaceuticals Lt... Live Price Chart

Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A FAQ

How is Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A today?

Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A today is trading in the red, and is down by -0.65% at 25.95.

How has Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A performed historically?

Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A is currently trading down -0.65% on an intraday basis. In the past week the stock rose 3.68%. stock has been up 29.62% in the past quarter and rose 33.97% in the past year. You can view this in the overview section.